Senior Women Web

During the COVID-19 pandemic, Americans have been exposed to a wide range of misinformation about masks and social distancing, treatments, and vaccines. As of late May, 67% of unvaccinated adults exit disclaimer icon had heard at least one COVID-19 vaccine myth and either believed it to be true or were not sure of its veracity. Health misinformation has already caused significant harm exit disclaimer icon, dividing families and communities and undermining vaccination efforts. An analysis of millions of social media posts exit disclaimer icon found that false news stories were 70 percent more likely to be shared than true stories. And a recent study exit disclaimer icon showed that even brief exposure to misinformation made people less likely to want a COVID-19 vaccine.  more »

Rose Madeline Mula Writes: Why does my computer crash only when I’m behind deadline on an important project and not when I’m playing solitaire — especially since I spend much more time playing games than working. And can wine connoisseurs really detect undertones of leather, tea, oak, and dozens of other essences and aromas? When they describe a certain vintage as having “a good nose” or “legs,” are they putting me on? And when they toss out adjectives like “assertive,” “attractive,” “graceful,” and “elegant,” are they really describing the wine or the waitress pouring it? If haste makes waste, how come he who hesitates is lost? And why should we keep our noses to the grindstone if all work and no play makes Jack a dull boy? No wonder I’m an insomniac.  How can I get to sleep when I keep trying to solve life’s little puzzles—like… How come the label on my sleeping pills warns, “May cause drowsiness”?  Isn’t that the point?  more »

Aduhelm, a new Alzheimer’s drug approved by the Food and Drug Administration last month, could be prescribed to 1 million to 2 million patients a year, even if conservative criteria were used, according to Biogen and Eisai, the companies behind the drug. The total annual price tag would come to $56 billion if the average list price, $56,000, is applied to the lower end of the companies’ estimate. That’s a huge sum by any measure — more than the annual budget for the National Institutes of Health (almost $43 billion this year). Yet there’s considerable uncertainty about Aduhelm’s clinical benefits, fueling controversy over its approval. The FDA has acknowledged it’s not clear whether the medication will actually slow the progression of Alzheimer’s disease or by how much. more »

Carol Christ: When I joined the faculty, only 3% of the faculty were women. When I joined the English department, there were 84 faculty in the English department — it was much bigger then than it is now — and there were four women. I was the fourth woman. And I remember whenever I went to an office, people didn’t believe I was a faculty member. Carol Clover: Or, when I went to Harvard, people always thought that I was a secretary in my office. They would just walk in and say, “Would you please type this for me and have it for tomorrow?” Anne Brice: What would you say? Carol Clover: It would be a nice conversation. They were usually apologetic. It was just the way things were." more »